Table 5.
Influence of diacetylmorphine (DAM) co-administration on morphine exposure after oral administration of a small dose of morphine d3 to opioid-dependent patients
DAM co-administration | No | Yes (1601 ± 323 µmol) | |
Morphine-d3 dose (µmol) | 48.5 | 48.5 | |
Morphine-d3 | |||
AUC (µmol h l−1) | 0.18 ± 0.07 | 0.24 ± 0.05 | |
Cmax (µmol l−1) | 0.14 ± 0.11 | 0.10 ± 0.03 | P = 0.1614 |
tmax (min) | 20 ± 11 | 13 ± 4 | P = 0.1468 |
F (%) | 37.2 ± 10.2 | 49.0 ± 5.8 | P = 0.0173 |
Morphine-d3-3-glucuronide | |||
AUC (µmol h l−1) | 2.87 ± 0.72 | 3.02 ± 0.66 | |
Morphine-d3-6-glucuronide | |||
AUC (µmol h l−1) | 0.55 ± 0.17 | 0.65 ± 0.16 | |
RatioG/N | 19.7 ± 4.3 | 23.8 ± 6.5 | P = 0.1614 |
P-values were calculated using Wilcoxon's matched-pairs test, n = 8.